Affordable Access

Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer.

Authors
  • Vogel, C L
  • Shemano, I
  • Schoenfelder, J
  • Gams, R A
  • Green, M R
Type
Published Article
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Date
Feb 01, 1993
Volume
11
Issue
2
Pages
345–350
Identifiers
PMID: 8426212
Source
Medline
License
Unknown

Abstract

We conclude that there is major cross-resistance between tamoxifen and toremifene and that only occasional tamoxifen-refractory patients will have objective responses to toremifene.

Report this publication

Statistics

Seen <100 times